A Green-Mediterranean Diet, Supplemented with Mankai Duckweed, Preserves Iron-Homeostasis in Humans and Is Efficient in Reversal of Anemia in Rats.


Journal

The Journal of nutrition
ISSN: 1541-6100
Titre abrégé: J Nutr
Pays: United States
ID NLM: 0404243

Informations de publication

Date de publication:
01 06 2019
Historique:
received: 18 10 2018
revised: 31 10 2018
accepted: 18 12 2018
pubmed: 28 3 2019
medline: 9 4 2020
entrez: 28 3 2019
Statut: ppublish

Résumé

Decreased dietary meat may deplete iron stores, as plant-derived iron bioavailability is typically limited. We explored the effect of a low-meat Mediterranean (green-MED) diet, supplemented with Wolffia globosa duckweed (Mankai: rich in protein and iron) as a food source for humans, on iron status. We further examined the iron bioavailability of Mankai in rats. Two hundred and ninety-four abdominally obese/dyslipidemic [mean age = 51.1 y; body mass index (kg/m2) = 31.3; 88% men] nonanemic participants were randomly assigned to physical activity (PA), PA + MED diet, or PA + green-MED diet. Both isocaloric MED groups consumed 28 g walnuts/d and the low-meat green-MED group further consumed green tea (800 mL/d) and Mankai (100 g green shake/d). In a complementary animal experiment, after 44 d of an iron deficiency anemia-inducing diet, 50 female rats (age = 3 wk; Sprague Dawley strain) were randomly assigned into: iron-deficient diet (vehicle), or vehicle + iso-iron: ferrous gluconate (FG) 14, Mankai 50, and Mankai 80 versions (1.7 mg · kg-1 · d-1 elemental iron), or FG9.5 and Mankai 50-C version (1.15 mg · kg-1 · d-1 elemental iron). The specific primary aim for both studies was changes in iron homeostasis parameters. After 6 mo of intervention, iron status trajectory did not differ between the PA and PA + MED groups. Hemoglobin modestly increased in the PA + green-MED group (0.23 g/dL) compared with PA (-0.1 g/dL; P < 0.001) and PA + MED (-0.1 g/dL; P < 0.001). Serum iron and serum transferrin saturation increased in the PA + green-MED group compared with the PA group (8.21 μg/dL compared with -5.23 μg/dL and 2.39% compared with -1.15%, respectively; P < 0.05 for both comparisons), as did folic acid (P = 0.011). In rats, hemoglobin decreased from 15.7 to 9.4 mg/dL after 44 d of diet-induced anemia. After depletion treatment, the vehicle-treated group had a further decrease of 1.3 mg/dL, whereas hemoglobin concentrations in both FG and Mankai iso-iron treatments similarly rebounded (FG14: +10.8 mg/dL, Mankai 50: +6.4 mg/dL, Mankai 80: +7.3 mg/dL; FG9.5: +5.1 mg/dL, Mankai 50-C: +7.1 mg/dL; P < 0.05 for all vs. the vehicle group). In humans, a green-MED low-meat diet does not impair iron homeostasis. In rats, iron derived from Mankai (a green-plant protein source) is bioavailable and efficient in reversal of anemia. This trial was registered at clinicaltrials.gov as NCT03020186.

Sections du résumé

BACKGROUND
Decreased dietary meat may deplete iron stores, as plant-derived iron bioavailability is typically limited.
OBJECTIVES
We explored the effect of a low-meat Mediterranean (green-MED) diet, supplemented with Wolffia globosa duckweed (Mankai: rich in protein and iron) as a food source for humans, on iron status. We further examined the iron bioavailability of Mankai in rats.
METHODS
Two hundred and ninety-four abdominally obese/dyslipidemic [mean age = 51.1 y; body mass index (kg/m2) = 31.3; 88% men] nonanemic participants were randomly assigned to physical activity (PA), PA + MED diet, or PA + green-MED diet. Both isocaloric MED groups consumed 28 g walnuts/d and the low-meat green-MED group further consumed green tea (800 mL/d) and Mankai (100 g green shake/d). In a complementary animal experiment, after 44 d of an iron deficiency anemia-inducing diet, 50 female rats (age = 3 wk; Sprague Dawley strain) were randomly assigned into: iron-deficient diet (vehicle), or vehicle + iso-iron: ferrous gluconate (FG) 14, Mankai 50, and Mankai 80 versions (1.7 mg · kg-1 · d-1 elemental iron), or FG9.5 and Mankai 50-C version (1.15 mg · kg-1 · d-1 elemental iron). The specific primary aim for both studies was changes in iron homeostasis parameters.
RESULTS
After 6 mo of intervention, iron status trajectory did not differ between the PA and PA + MED groups. Hemoglobin modestly increased in the PA + green-MED group (0.23 g/dL) compared with PA (-0.1 g/dL; P < 0.001) and PA + MED (-0.1 g/dL; P < 0.001). Serum iron and serum transferrin saturation increased in the PA + green-MED group compared with the PA group (8.21 μg/dL compared with -5.23 μg/dL and 2.39% compared with -1.15%, respectively; P < 0.05 for both comparisons), as did folic acid (P = 0.011). In rats, hemoglobin decreased from 15.7 to 9.4 mg/dL after 44 d of diet-induced anemia. After depletion treatment, the vehicle-treated group had a further decrease of 1.3 mg/dL, whereas hemoglobin concentrations in both FG and Mankai iso-iron treatments similarly rebounded (FG14: +10.8 mg/dL, Mankai 50: +6.4 mg/dL, Mankai 80: +7.3 mg/dL; FG9.5: +5.1 mg/dL, Mankai 50-C: +7.1 mg/dL; P < 0.05 for all vs. the vehicle group).
CONCLUSIONS
In humans, a green-MED low-meat diet does not impair iron homeostasis. In rats, iron derived from Mankai (a green-plant protein source) is bioavailable and efficient in reversal of anemia. This trial was registered at clinicaltrials.gov as NCT03020186.

Identifiants

pubmed: 30915471
pii: S0022-3166(22)16627-7
doi: 10.1093/jn/nxy321
doi:

Substances chimiques

Iron, Dietary 0
Iron E1UOL152H7

Banques de données

ClinicalTrials.gov
['NCT03020186']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1004-1011

Informations de copyright

Copyright © American Society for Nutrition 2019.

Auteurs

Anat Yaskolka Meir (A)

Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Gal Tsaban (G)

Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Hila Zelicha (H)

Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Ehud Rinott (E)

Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Alon Kaplan (A)

Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Ilan Youngster (I)

Division of Pediatrics and the Microbiome Research Center, Assaf Harofeh Medical Center, Zerifin, Israel.

Assaf Rudich (A)

Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Ilan Shelef (I)

Soroka University Medical Center, Beer-Sheva, Israel.

Amir Tirosh (A)

Endocrinology and Diabetes Research Center at Sheba Medical Center, Ramat Gan, Israel.
Harvard TH Chan School of Public Health and Channing Division of Network Medicine, Department of Medicine, Harvard Medical School and Brigham and Women's Hospital, Boston, MA.

Dov Brikner (D)

Department of Medicine, Nuclear Research Center Negev, Dimona, Israel.

Efrat Pupkin (E)

Department of Medicine, Nuclear Research Center Negev, Dimona, Israel.

Benjamin Sarusi (B)

Department of Medicine, Nuclear Research Center Negev, Dimona, Israel.

Matthias Blüher (M)

Department of Medicine, University of Leipzig, Leipzig, Germany.

Michael Stümvoll (M)

Department of Medicine, University of Leipzig, Leipzig, Germany.

Joachim Thiery (J)

Department of Medicine, University of Leipzig, Leipzig, Germany.

Uta Ceglarek (U)

Department of Medicine, University of Leipzig, Leipzig, Germany.

Meir J Stampfer (MJ)

Harvard TH Chan School of Public Health and Channing Division of Network Medicine, Department of Medicine, Harvard Medical School and Brigham and Women's Hospital, Boston, MA.

Iris Shai (I)

Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH